INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 283 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,207,777 | -22.5% | 1,145,091 | 0.0% | 3.72% | -12.7% |
| Q2 2023 | $46,696,811 | +9.4% | 1,145,091 | 0.0% | 4.26% | +11.3% |
| Q1 2023 | $42,677,542 | +6.8% | 1,145,091 | 0.0% | 3.83% | -28.4% |
| Q4 2022 | $39,952,225 | -40.1% | 1,145,091 | -3.9% | 5.34% | -24.4% |
| Q3 2022 | $66,659,000 | +5.9% | 1,191,193 | -2.1% | 7.07% | +0.5% |
| Q2 2022 | $62,958,000 | +16.4% | 1,216,340 | +63.5% | 7.04% | +21.5% |
| Q1 2022 | $54,078,000 | -22.5% | 744,160 | +26.1% | 5.79% | +8.4% |
| Q4 2021 | $69,790,000 | +23.6% | 590,240 | +40.2% | 5.34% | +21.3% |
| Q3 2021 | $56,458,000 | +16.1% | 420,859 | +40.1% | 4.40% | -6.9% |
| Q2 2021 | $48,626,000 | +2521.3% | 300,327 | +1199.0% | 4.72% | +1080.8% |
| Q1 2021 | $1,855,000 | – | 23,120 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |